917480-07-0

Basic information

• Product Name: Carbamic acid, N-[2-[4-[[bis(1,1-dimethylethoxy)phosphinyl]oxy]-3-formylphenyl]-2-hydro xyethyl]-N-[6-(4-phenylbutoxy)hexyl]-, 1,1-dimethylethyl ester
• Synonyms: tert-Butyl (2-(4-((di-tert-butoxyphosphoryl)oxy)-3-formylphenyl)-2-hydroxyethyl)(6-(4-phenylbutoxy)hexyl)carbamate
• CAS NO: 917480-07-0
• Molecular Formula: C38H60NO9P
• Molecular Weight: 705.869
• Mol File: 917480-07-0.mol

Chemical Properties

• CAS DataBase Reference: Carbamic acid, N-[2-[4-[[bis(1,1-dimethylethoxy)phosphinyl]oxy]-3-formylphenyl]-2-hydro xyethyl]-N-[6-(4-phenylbutoxy)hexyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, N-[2-[4-[[bis(1,1-dimethylethoxy)phosphinyl]oxy]-3-formylphenyl]-2-hydro xyethyl]-N-[6-(4-phenylbutoxy)hexyl]-, 1,1-dimethylethyl ester(917480-07-0)
• EPA Substance Registry System: Carbamic acid, N-[2-[4-[[bis(1,1-dimethylethoxy)phosphinyl]oxy]-3-formylphenyl]-2-hydro xyethyl]-N-[6-(4-phenylbutoxy)hexyl]-, 1,1-dimethylethyl ester(917480-07-0)

Safety Data

• Hazardous Substances Data: 917480-07-0(Hazardous Substances Data)

Upstream product

• 917480-06-9 [2-(3-formyl-4-hydroxy-phenyl)-2-hydroxy-ethyl]-[6-(4-phenyl-butoxy)-hexyl]-carbamic acid tert-butyl ester 
• 59346-65-5 di-tert-butyl phosphorobromidate 
• 13086-84-5 di-tert-butyl phosphite 

Downstream Products

• 1200407-14-2 1-[[5-[1-hydroxy-2-[(t-butoxycarbonyl)[6-(4-phenylbutoxy)hexyl]amino]ethyl]-2-(di-tert-butylphosphoryloxy)benzyl]amino]acetic acid [[11β,16α]-[15,16-((R)-cyclohexylmethylene)bis(oxy)]-11-hydroxypregna-1,4-diene-3,20-dion-21-yl]ester 
• 917480-08-1 {2-[4-(di-tert-butoxy-phosphoryloxy)-3-hydroxymethyl-phenyl]-2-hydroxy-ethyl}-[6-(4-phenyl-butoxy)-hexyl]-carbamic acid tert-butyl ester 

Relevant articles and documents

CORTICOSTEROID LINKED BETA-AGONIST COMPOUNDS FOR USE IN THERAPY

New chemical entities which comprise corticosteroids and phosphorylated β-agonists for use in therapy and compositions comprising and processes for preparing the same.

MONOPHOSPHATES AS MUTUAL PRODRUGS OF ANTI-INFLAMMATORY SIGNAL TRANSDUCTION MODULATORS (AISTM'S) AND β-AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION

A mutual prodrug of an AISTM and a β-agonist in formulation for delivery by aerosolization to inhibit pulmonary inflammation and bronchoconstriction is described. The mutual prodrug is preferably formulated in a small volume solution (10-500 μL) dissolved

MONOPHOSPHATES AS MUTUAL PRODRUGS OF MUSCARINIC RECEPTOR ANTAGONISTS AND B-AGONISTS FOR THE TREATMENT OF COPD AND CHRONIC BRONCHITIS

A mutual prodrug of a MRA and a β-agonist for formulation for delivery by aerosolization to inhibit pulmonary bronchoconstriction is described. The mutual prodrug is preferably formulated in a small volume solution (10-500 μL) dissolved in a quarter norma

SUBSTITUTED PHENYLPHOSPHATES AS MUTUAL PRODRUGS OF STEROIDS AND β -AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION

A mutual prodrug of a corticosteroid and a substituted phenylphosphate (β-agonist derivative) for formulation for delivery by aerosolization to inhibit pulmonary inflammation and bronchoconstriction is described. The mutual prodrug is preferably formulate